H

Hypera
HYPE3

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
R$17.56B
EV
R$25.37B
Shares Outstanding
631.80M
Beta
0.37

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
R$25.93
P/E 2025E
14.18x
P/Revenue 2025E
2.14x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hypera S.A.

gainify

H

Hypera S.A.

HYPE3

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Pires de Oliveira, Breno

Employees

10,481

IPO Date

2008-04-18

Headquarters

Av. Magalhães de Castro, 4800, 240 Floor, Continental Tower Building, Bairro Cidade Jardim, São Paulo, São Paulo, 05676-120, Brazil

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.